NEW PAPER ABOUT SUL-109

There is a new manuscript available which describes the positive effect of our SUL-109 compound which is commercially available as our ROKEPIE preservation solution. This article was written by Fatima Aerts from the Hacettepe University in Ankara (Turkey). You can read the complete article on the Biology of Blood and Marrow Transplantation website. Hypothermic storage Read More

HypoThermosol and ROKEPIE compared

A direct comparison of HypoThermosol® (Biolife Solutions) and ROKEPIE (Sulfateq) was recently published in PlosONE. Freitas Robero from the group of Prof Rui Reis (CEO of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine) used both agents for their intended application: The hypothermic preservation of cells for multiple days. The authors found Read More

Development of ROKEPIE for medical device market

ROKEPIE® makes it possible to preserve cells and tissues at low temperatures (2-8 ° C). Sulfateq wants to develop ROKEPIE further into a product for clinical applications and more specifically a preservation solution for multiple applications. To make our plans possible we receive financial support from the European Regional Development Fund of the European Union.

New publications about ROKEPIE

Lately there is a lot of happening at Sulfateq which is very positive for the development of ROKEPIE. Besides our new website there are also multiple publications and papers which have been published or will be published in the near future. What’s even greater is that all of these publications show the strength of ROKEPIE and Read More